Boston Commerce Limited has issued a regulatory disclosure pursuant to Regulations 30 and 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company is sending a letter containing a web-link for accessing the Annual Report for the financial year 2025-26 to shareholders whose email addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA)/Depositories/Depository Participant(s).

The Annual Report for FY 2025-26, including the Notice of the 31st Annual General Meeting, is available on the company's website at www.bostonbio.in.

The 31st Annual General Meeting of the Company is scheduled to be held on Wednesday, September 30, 2026 at 5:00 P.M. (IST) through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

The letter was signed by Archana Chaitanya Pandya, Additional Whole-Time Director & Chief Financial Officer (DIN: 10147795), on September 11, 2026. The company's registered office is located at Office No. 11, Krishna Complex, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, 380009, with CIN: L62013GJ1995PLC025476.